| Cas No.: | 25332-39-2 |
| Chemical Name: | 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride |
| Synonyms: | Trazodone, Trazodon, AF-1161, Beneficat, AF 1161, AF1161; Trazodone HCl |
| SMILES: | Cl.ClC1=CC=CC(N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2)=C1 |
| Formula: | C19H23Cl2N5O |
| M.Wt: | 408.327 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | Trazodone HCl is an antidepressant belonging to the class of serotonin receptor antagonists and reuptake inhibitors for treatment of anxiety disorders.Trazodone is a triazolopyridine derivative, chemically and pharmacologically unrelated to other currently available antidepressants. Trazodone has been successfully used in a small number of patients with depression and pre-existing cardiovascular disease. trazodone has also been used as a hypnotic for psychotropic-induced or other insomnias with some success. Trazodone is an effective hypnotic for patients with antidepressant-associated insomnia. Trazodone may be helpful in men with erectile dysfunction (ED), possibly more so at higher doses, and in men with psychogenic ED. Future high-quality trials should compare trazodone with placebo and other therapies in men with depression and psychogenic ED. |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|